RIZATRIPTAN BENZOATE

Generic: RIZATRIPTAN BENZOATE

Cipla USA Inc.Manufacturer
ORALRoute
RIZATRIPTAN BENZOATEActive Substance
2013-07-01Original Approval

RIZATRIPTAN BENZOATE is FDA application ANDA204339, sponsored by INVAGEN PHARMS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Class III2021-10-18
Rizatriptan Benzoate Orally Disintegrating Tablets 10mg, 18 Tablets (3 x 6 Unit-Dose Tablets) Blister Packs, Rx only, Ma

Out-of-specification test results obtained in Organic Impurities test during analysis of controlled

Class II2024-05-13
Rizatriptan Benzoate Orally Disintegrating Tablets, USP 10mg, 18 (3 x 6) Unit-Dose Tablets, Manufactured for: Glenmark P

CGMP Deviations: N-Nitroso Desmethyl Rizatriptan Impurity results that are above the FDA acceptable

Class II2025-07-09
Rizatriptan Benzoate Tablets, USP, 10 mg, 18 (3x6) Unit Dose Tablets, Rx Only, Manufactured by: Alkem Laboratories Ltd.,

CGMP Deviations: detection of N-nitroso-dimethyl-rizatriptan impurity, above the FDA recommended acc

Class II2024-05-10
Rizatriptan Benzoate Tablets USP, 5mg, 18 (3 X 6) Unit-Dose Tablets, Manufactured for: Glenmark Pharmaceuticals Inc., US

CGMP Deviations: N-Nitroso Desmethyl Rizatriptan Impurity results that are above the FDA acceptable

Class II2024-05-13
Rizatriptan Benzoate Orally Disintegrating Tablets, USP 5mg, 18 (3 x 6) Unit-Dose Tablets, Manufactured for: Glenmark Ph

CGMP Deviations: N-Nitroso Desmethyl Rizatriptan Impurity results that are above the FDA acceptable

Class III2021-10-18
Rizatriptan Benzoate Orally Disintegrating Tablets 5mg, 12 Tablets (2 x 6 Unit-Dose Tablets) Blister Packs, Rx only, Ma

Out-of-specification test results obtained in Organic Impurities test during analysis of controlled

Class II2024-05-10
Rizatriptan Benzoate Tablets USP, 10 mg, 18 (3 X 6) Unit-Dose Tablets, Manufactured for: Glenmark Pharmaceuticals Inc.,

CGMP Deviations: N-Nitroso Desmethyl Rizatriptan Impurity results that are above the FDA acceptable

Class II2025-07-09
Rizatriptan Benzoate Tablets, USP, 5 mg, 18 (3x6) Unit Dose Tablets, Rx Only, Manufactured by: Alkem Laboratories Ltd.,

CGMP Deviations: detection of N-nitroso-dimethyl-rizatriptan impurity, above the FDA recommended acc

Top Reported Reactions

1
DRUG INEFFECTIVE
420 reports
2
HEADACHE
259 reports
3
OFF LABEL USE
246 reports
4
NAUSEA
239 reports
5
MIGRAINE
204 reports
6
PRODUCT USE IN UNAPPROVED INDICATION
178 reports
7
DRUG INTOLERANCE
175 reports
8
HYPERSENSITIVITY
169 reports
9
FATIGUE
140 reports
10
SWELLING FACE
132 reports